PURPOSE: This study explored neuromuscular mechanisms and clinical measures that
contribute to countermovement jump performance in survivors of childhood acute …

Objectives: This quasi-experimental study examined the efficacy of targeted exercise
training on gross motor performance and neuromuscular impairments in survivors of …

Background: Acute lymphoblastic leukemia childhood cancer survivors (ALL CCS) are at
risk for long-term musculoskeletal and neuromuscular deficits in balance, motor proficiency …

Background Chronicity of muscle weakness from cancer and its treatment may be
problematic, particularly in those treated for cancer during childhood. We compared body …

This study describes skeletal, neuromuscular and fitness impairments among 109 children
(median age 10 [range 4–18] years, 65.1% male, 63.3% white) with acute lymphoblastic …

Background Impaired motor performance and reduced maximum exercise capacity during
and after treatment of acute lymphoblastic leukemia (ALL) has been shown. However, no …

BACKGROUND: Treatment regimens for childhood acute lymphoblastic leukemia (ALL)
contain neurotoxic agents that may interfere with neuromuscular health. In this study, the …

Abstract Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children and
toxicities related to treatment are common. One of these adverse effects is related to the …

Background After acute lymphoblastic leukemia (ALL) treatment, children can have
persistent muscle weakness, range of motion limitations, and decreased function after …

Purpose: This cross-sectional, observational study investigated whether physical activity
(PA) levels are associated with motor performance and physical function in children after …